The Bush administration's international AIDS program has been hailed as a success story, but will President-elect Obama follow through with a higher quality, fewer-strings-attached plan?
Despite disappointing study results, scientists haven't given up on creating an effective way for women to protect themselves against HIV
Once the bane of global activists and politicians in developing nations, pre-exposure HIV preventatives are being tested in AIDS-stricken Africa
We unpack whether a controversial prevention method works
Repeated failures in the quest for an AIDS vaccine have sent investigators back to the drawing board
The battle must continue, even if 25 years of research have disappointed
Among the unresolved issues surrounding the AIDS pandemic is which strategy — pushing prevention techniques or HIV treatments — will best reduce the disease's spread.
Physiology or medicine prize recognizes work on HIV and human papillomavirus (HPV) linked to cervical cancer--but leaves out Robert Gallo
In their first collaborative article 20 years ago, 2008 Nobel Prize winner Luc Montagnier, along with Robert Gallo, co-investigators who discovered HIV, introduced a Scientific American single-topic issue on AIDS. They recounted the breakthrough and offered prospects for vaccine, for therapy and for the epidemic
More than 1.1 million people in the U.S. are living with human immunodeficiency virus (HIV), as more people are infected with the AIDS-causing virus than die from it each year.
If you study prostitutes, would you tell the NIH?
Half of scientists whose federally funded research — most of it about sex and AIDS — was subjected to extra scrutiny by the National Institutes of Health (NIH) in 2003 after conservative members of Congress questioned its merits say they now censor wording in their grant applications that might raise "red flags" at the agency, according to a new survey.
Some researchers say johns seek intimacy on demand; others believe these men typically want to use and dominate women
Efforts to devise vaccines and treatments for HIV depend on knowledge of the virus's life cycle
In Africa, patients and doctors battle the double whammy of AIDS and TB
Peptide nucleic acid, a synthetic hybrid of protein and DNA, could form the basis of a new class of drugs—and of artificial life unlike anything found in nature
The big challenges in the fight against HIV/AIDS